Day: August 6, 2025

Blink Charging Reschedules Release of Second Quarter 2025 Results and Conference Call to August 18

Written by Customer Service on August 6, 2025. Posted in Public Companies.

Bowie, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global, owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced that it has rescheduled its previously announced earnings conference call. The Company will now host a conference call to review second quarter 2025 results after the stock market closes on Monday, August 18. Blink will issue a press release reporting its results, which will be available on the Investor Relations section of its website. Management will then host a conference call and webcast for investors and analysts at 4:30 P.M. ET to discuss the results. To access the live webcast, log onto the Blink Charging website at www.blinkcharging.com, and click on the News/Events section of the Investor Relations...

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Written by Customer Service on August 6, 2025. Posted in Public Companies.

Trial now over 60% enrolled with 125 of 200 anticipated patients Recent new site activation brings total clinical trial sites to 16 Interim analysis of first 100 patients remains on track for 3Q 2025 DENVER, Aug. 06, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it has successfully reached enrollment of 125 patients in the NEUTRALIZE-AKI pivotal clinical trial. Additionally, it has activated Methodist Hospital Metropolitan of San Antonio, Texas, as its 16th clinical trial site. The company also reported that it remains on track to receive results from the per protocol prespecified interim analysis of the first 100 patients in the trial...

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025

Written by Customer Service on August 6, 2025. Posted in Earnings Releases And Operating Results.

NESS ZIONA, Israel, Aug. 06, 2025 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it will report its second quarter 2025 financial results and program updates before the open of the U.S. financial markets on Wednesday, August 13, 2025. The Company will host a conference call and a live audio webcast at 8 a.m. ET, to discuss the second quarter of 2025 financial results and provide program updates. To ensure you are connected prior to the beginning of the call, BiomX suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the webcast. Conference Call...

Evolution Closes Mineral & Royalty Acquisition, Adding Long-Term Production and Cash Flow

Written by Customer Service on August 6, 2025. Posted in Mergers And Acquisitions.

HOUSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) — Evolution Petroleum Corporation (NYSE American: EPM) (“Evolution” or the “Company”) today announced the closing of an acquisition of mineral and royalty interests in the SCOOP/STACK area of Oklahoma from a non-affiliated private seller in a cash transaction valued at approximately $17 million, subject to customary post-closing adjustments. The acquisition, effective May 1, 2025 (the “Effective Date”), was funded through a combination of cash on hand and borrowings under the Company’s existing credit facility. The Company expects to receive the vast majority of the cash flow earned between the Effective Date and the closing date, August 4, 2025, within the next 90 days through receipt of a final closing statement. Acquisition Highlights:Mineral and Royalty...

Apollo Funds to Acquire Majority Stake in Stream Data Centers, Forming a Scaled Digital Infrastructure Leader

Written by Customer Service on August 6, 2025. Posted in Mergers And Acquisitions.

Apollo’s Long-Term Capital to Accelerate Stream’s 4+ GW Development Pipeline and Enable Deployment of Billions Into Critical U.S. Infrastructure NEW YORK and DALLAS, Aug. 06, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds (the “Apollo Funds”) have agreed to acquire a majority interest in Stream Data Centers (“SDC” or the “Company”) from Stream Realty Partners (“SRP”). With Apollo’s backing, SDC is positioned to execute on a multi-gigawatt pipeline while enabling Apollo Funds and affiliates to potentially deploy billions of dollars into next-generation digital infrastructure. SDC’s management team will retain a minority stake and continue leading the business. SDC builds, leases, manages and operates hyperscale data center campuses and has delivered more than 20 campuses to date. The Company...

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Written by Customer Service on August 6, 2025. Posted in Public Companies.

BERKELEY, Calif, Aug. 06, 2025 (GLOBE NEWSWIRE) — Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, provides a strategy overview and business update from Chairman and CEO, Ben Hwang, Ph.D. in the following Letter to Shareholders: To our valued shareholders, In the last two months, Profusa has achieved significant milestones, including securing investment and becoming a public company that is trading on the Nasdaq Market under the ticker PFSA on July 14, 2025. With these essential steps behind us, we are now fully committed to bring our groundbreaking personalized biochemistry technology platform to the clinical community and drive growth in our business. We...

Regency Centers Declares Quarterly Dividends

Written by Customer Service on August 6, 2025. Posted in Dividend Reports And Estimates.

JACKSONVILLE, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency Centers,” “Regency” or the “Company”) (NASDAQ: REG) announced today that the Company’s Board of Directors (the “Board”) declared quarterly cash dividends on Regency’s common stock, Series A preferred stock, and Series B preferred stock.On August 5, 2025, the Board declared a quarterly cash dividend on the Company’s common stock of $0.705 per share. The dividend is payable on October 2, 2025, to shareholders of record as of September 11, 2025. On August 5, 2025, the Board declared a quarterly cash dividend on the Company’s Series A preferred stock of $0.390625 per share. The dividend is payable on October 31, 2025, to shareholders of record as of October 16, 2025. On August 5, 2025, the Board declared a quarterly cash dividend on the Company’s...

United Maritime Reports Second Quarter and First Half Financial Results for the Periods Ended June 30, 2025

Written by Customer Service on August 6, 2025. Posted in Dividend Reports And Estimates.

Declares Quarterly Cash Dividend of $0.03 Per ShareHighlights (in million USD, except EPS & LPS) Q2 2025 Q2 2024 6M 2025 6M 2024Net Revenues $12.5 $12.4 $20.2 $23.0 Net income / (loss) $1.0 $0.7 ($3.5) ($0.7) Adjusted net income / (loss)1 $0.2 $0.9 ($4.2) ($0.2) EBITDA1 $5.9 $6.0 $6.6 $9.5 Adjusted EBITDA1 $5.1 $6.3 $6.0 $10.0 Earnings / (loss) per share Basic $0.11 $0.08 ($0.40) ($0.08) Earnings / (loss) per share Diluted $0.11 $0.07 ($0.40) ($0.08) Adjusted earnings / (loss) per share Basic1 $0.02 $0.10 ($0.48) ($0.02) Adjusted earnings / (loss) per share Diluted1 $0.02 $0.09 ($0.48) ($0.02) Other Highlights and Developments:Consistent Shareholder Returns: Declared a quarterly cash dividend of $0.03 per share...

FTAI Infrastructure Inc. Announces Agreement to Acquire the Wheeling & Lake Erie Railway Company

Written by Customer Service on August 6, 2025. Posted in Mergers And Acquisitions.

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — FTAI Infrastructure Inc. (NASDAQ:FIP) (the “Company” or “FIP”) announced today that it has agreed to purchase The Wheeling Corporation, owner of the Wheeling & Lake Erie Railway Company (the “W&LE”), for cash consideration of $1.05 billion from an entity controlled by Larry Parsons, the CEO of The Wheeling Corporation. The W&LE is a Class II regional freight railroad serving more than 250 customers along over 1,000 miles of track in the states of Ohio, Pennsylvania, West Virginia, and Maryland. The W&LE connects to Transtar’s Union Railroad Company, LLC outside of Pittsburgh, Pennsylvania. Simultaneously with the closing of the acquisition, FIP plans to refinance its existing10.50% senior notes and Series A preferred stock. The Company has received commitments for $2.25...

NKGen Biotech To Present on Allogeneic Enhanced NK Cells without Lymphodepletion in Solid Tumors at the 13th Annual Immuno-Oncology Summit

Written by Customer Service on August 6, 2025. Posted in Public Companies.

SANTA ANA, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that Paul Y. Song, M.D., Chairman and Chief Executive Officer of NKGen, will present at the 13th Annual Immuno-Oncology Summit (the “Summit”) to be held in Philadelphia, PA, from August 11 – 13, 2025. The Summit is a leading global event in cancer immunotherapy. Organized by Cambridge Healthtech Institute, the summit brings together top experts from industry and academia to explore the latest advances in cell therapies, innate immunity, bispecifics, and translational strategies. With multiple scientific tracks, high-impact presentations,...

Day: August 6, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals